Home The Word Brain My Amedeo FAQ Privacy About   

As of October 2023, Amedeo had
12,263 active subscribers

  Inflammatory Bowel Diseases

  Free Subscription


3 Aliment Pharmacol Ther
8 Am J Gastroenterol
1 Am J Surg
1 BMC Gastroenterol
1 Clin Gastroenterol Hepatol
2 Dig Dis Sci
1 Gastroenterol Hepatol
1 Gastroenterology
5 Inflamm Bowel Dis
1 J Crohns Colitis
1 PLoS One
2 Scand J Gastroenterol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Aliment Pharmacol Ther

  1. KELLER JJ, Terveer EM
    Editorial: Continuous monitoring to improve outcome of treatment-the next step towards safe and effective faecal microbiota transplantation.
    Aliment Pharmacol Ther. 2023;58:946-947.

  2. DAN L, Wang X, Chen J
    Editorial: Unravelling the fibres-low dietary fibre may lower risk of developing IBD. Authors' reply.
    Aliment Pharmacol Ther. 2023;58:940-941.

  3. LOPES EW, Khalili H
    Editorial: Unravelling the fibres-low dietary fibre may lower risk of developing IBD.
    Aliment Pharmacol Ther. 2023;58:938-939.

    Am J Gastroenterol

  4. ANDREW B, Vasudevan A, Srinivasan A
    The Role of Intestinal Ultrasound During Pregnancy in Patients With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2023;118:2096-2097.

  5. BARNES EL, Desai A, Kochhar GS
    The Comparative Effectiveness of Ciprofloxacin and Metronidazole for an Initial Episode of Pouchitis: A Propensity-Matched Study.
    Am J Gastroenterol. 2023;118:1989-1996.
    PubMed         Abstract available

  6. SANTIAGO P, Barnes EL, Raffals LE
    Classification and Management of Disorders of the J Pouch.
    Am J Gastroenterol. 2023;118:1931-1939.
    PubMed         Abstract available

  7. SACHDEVA K, Agarwal S, Kumar P, Mathew D, et al
    Revised Algorithmic Approach to Differentiate Between Nonspecific and Specific Etiologies of Chronic Terminal Ileitis.
    Am J Gastroenterol. 2023;118:2052-2060.
    PubMed         Abstract available

  8. YARUR AJ, Abreu MT, Deepak P, Beniwal-Patel P, et al
    Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission.
    Am J Gastroenterol. 2023;118:2005-2013.
    PubMed         Abstract available

  9. MOHAN BP, Fatima N, Khan SR, Kassab L, et al
    Early Remission With Induction Therapy Predicts Long-Term Remission in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2023;118:2084-2087.

  10. KOCHAR B, Mao EJ, Shah SA
    Optimal Dysplasia Detection and Management in IBD: Now and in the Future.
    Am J Gastroenterol. 2023;118:1905-1908.

  11. DUNLEAVY KA, Cross RK, Raffals LE
    Causes, Diagnostic Testing, and Treatment of Residual Symptoms in Patients With IBD With Quiescent Disease.
    Am J Gastroenterol. 2023;118:1909-1914.

    Am J Surg

  12. HOLUBAR SD, Lipman J, Steele SR, Uchino T, et al
    Safety & feasibility of targeted mesenteric approaches with Kono-S anastomosis and extended mesenteric excision in ileocolic resection and anastomosis in Crohn's disease.
    Am J Surg. 2023 Oct 26:S0002-9610(23)00578-0. doi: 10.1016/j.amjsurg.2023.
    PubMed         Abstract available

    BMC Gastroenterol

  13. ZHANG Z, Kong L, Lv M, Yao Y, et al
    PVA enema ameliorates DSS-induced acute colitis in mice.
    BMC Gastroenterol. 2023;23:368.
    PubMed         Abstract available

    Clin Gastroenterol Hepatol

  14. MARILD K, Soderling J, Axelrad J, Halfvarson J, et al
    Histological activity in inflammatory bowel disease and risk of serious infections: A nationwide study.
    Clin Gastroenterol Hepatol. 2023 Oct 30:S1542-3565(23)00855.
    PubMed         Abstract available

    Dig Dis Sci

  15. BERINSTEIN EM, Sheehan JL, Jacob J, Steiner CA, et al
    Correction to: Efficacy and Safety of Dual Targeted Therapy for Partially or Non?responsive Inflammatory Bowel Disease: A Systematic Review of the Literature.
    Dig Dis Sci. 2023 Oct 27. doi: 10.1007/s10620-023-08130.

  16. PIPICELLA JL, Vernon-Roberts A, Dutt S, Giles E, et al
    Co-design and Consultation Ensure Consumer Needs Are Met: Building an eHealth Platform for Children with Inflammatory Bowel Disease.
    Dig Dis Sci. 2023 Oct 28. doi: 10.1007/s10620-023-08146.
    PubMed         Abstract available

    Gastroenterol Hepatol

  17. SILVA ACV, Tumelero TJ, Yamamoto DR, Truppel SK, et al
    Biological therapy, surgery, and hospitalization rates for inflammatory bowel disease: an observational Latin American comparative study between adults and pediatric patients.
    Gastroenterol Hepatol. 2023 Oct 25:S0210-5705(23)00452.
    PubMed         Abstract available


  18. LEE HH, Singh S
    Quantifying Endoscopic Activity in Ulcerative Colitis: Innovation, Powered by AI.
    Gastroenterology. 2023 Oct 30:S0016-5085(23)05201.

    Inflamm Bowel Dis

  19. KRUGLIAK CLEVELAND N, Ghosh S, Chastek B, Bancroft T, et al
    Real-World Persistence of Successive Biologics in Patients With Inflammatory Bowel Disease: Findings From ROTARY.
    Inflamm Bowel Dis. 2023 Oct 31:izad245. doi: 10.1093.
    PubMed         Abstract available

  20. GUO A, Ostensson M, Stordal K, Ludvigsson J, et al
    Early-Life Hygiene-Related Factors and Risk of Inflammatory Bowel Disease: A Scandinavian Birth Cohort Study.
    Inflamm Bowel Dis. 2023 Oct 31:izad257. doi: 10.1093.
    PubMed         Abstract available

  21. FU J, Chai C, Chen L, Cai M, et al
    Associations of Fish and Fish Oil Consumption With Incident Inflammatory Bowel Disease: A Population-Based Prospective Cohort Study.
    Inflamm Bowel Dis. 2023 Oct 27:izad262. doi: 10.1093.
    PubMed         Abstract available

  22. HUANG Z, Cheng W, Chao K, Tang J, et al
    Baseline and Postinduction Intestinal Ultrasound Findings Predict Long-term Transmural and Mucosal Healing in Patients With Crohn's Disease.
    Inflamm Bowel Dis. 2023 Oct 27:izad251. doi: 10.1093.
    PubMed         Abstract available

  23. ASSADSANGABI A, Evans CA, Corfe BM, Lobo AJ, et al
    Exploring Predictive Biomarkers of Relapse in Ulcerative Colitis: A Proteomics Approach.
    Inflamm Bowel Dis. 2023 Oct 27:izad241. doi: 10.1093.
    PubMed         Abstract available

    J Crohns Colitis

  24. BOYD T, Araka EB, Kochar B, Ananthakrishnan AN, et al
    Differences in Management and Outcomes of Older and Younger Adults with Acute Severe Ulcerative Colitis.
    J Crohns Colitis. 2023 Oct 28:jjad183. doi: 10.1093.
    PubMed         Abstract available


  25. SURAN M
    Highlights From Gastroenterology Week: New Crohn Disease Drug, Redefining Liver Disease, and More.
    JAMA. 2023 Nov 2. doi: 10.1001/jama.2023.19140.

    PLoS One

  26. CHAE K, Seo YS, Yu YM, Chang MJ, et al
    An indirect comparison of efficacy including histologic assessment and safety in biologic therapy in ulcerative colitis: Systemic review and network meta-analysis.
    PLoS One. 2023;18:e0293655.
    PubMed         Abstract available

    Scand J Gastroenterol

  27. WANG L, Zhang Y, Wu H, Tang Z, et al
    Intestinal ultrasound score predicts therapeutic outcomes of infliximab in pediatric patients with Crohn's disease.
    Scand J Gastroenterol. 2023 Oct 31:1-8. doi: 10.1080/00365521.2023.2271110.
    PubMed         Abstract available

  28. NURMI E, Rantanen A, Paavilainen E, Haapamaki J, et al
    A quality assessment of inflammatory bowel disease nursing care in Finland: a nationwide cross-sectional descriptive study.
    Scand J Gastroenterol. 2023 Oct 30:1-5. doi: 10.1080/00365521.2023.2276654.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.